RxReasoner presents a comprehensive list of pharmaceutical treatment indications drawn from medicine package inserts issued by authoritative regulatory bodies globally.
This index serves as a valuable tool to quickly access information on the recommended therapeutic approaches for different medical conditions, diseases or symptoms.
Select a letter from the index list.
| Indication | Treatments |
|---|---|
| Juvenile idiopathic arthritis |
Abatacept
: Polyarticular juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Acetylsalicylic acid
: Juvenile rheumatoid arthritis, osteoarthritis
–
only
adolescents (12 years - 18 years old)
Adalimumab
: Polyarticular juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Baricitinib
: Juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Etanercept
: Juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Golimumab
: Polyarticular juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Hydroxychloroquine
: Juvenile idiopathic arthritis, discoid and systemic lupus erythematosus
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Ibuprofen
: Juvenile rheumatoid arthritis
–
only
infants (40 days - 1 year old)
, children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Naproxen
: Juvenile rheumatoid arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Triamcinolone
: Rheumatoid arthritis, juvenile idiopathic arthritis, osteoarthritis, post-traumatic arthritis, synovitis, tendinitis, bursitis
–
only
adolescents (12 years - 18 years old)
, adults (18 years old or older)
|
| Juvenile idiopathic arthritis, enthesitis related arthritis |
Adalimumab
: Enthesitis-related arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
Secukinumab
: Juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
| Juvenile myxedema |
Levothyroxine
: Juvenile myxedema
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
| Juvenile psoriatic arthritis |
Secukinumab
: Juvenile idiopathic arthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
| Juvenile seronegative polyarthritis |
Tocilizumab
: Juvenile idiopathic polyarthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
| Juvenile seropositive polyarthritis |
Tocilizumab
: Juvenile idiopathic polyarthritis
–
only
children (1 year - 12 years old)
, adolescents (12 years - 18 years old)
|
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
